BIOMAT Database Logo BIOMAT Database Logo

Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. 1995

K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Molecular Disease Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

The cholesteryl ester transfer protein (CETP) transfers lipids among lipoprotein particles and plays a central role in lipoprotein metabolism. Humans with genetic deficiency of CETP have both elevated HDL cholesterol and apolipoprotein A-I concentrations as well as decreased LDL cholesterol and apolipoprotein B levels. The present study was undertaken to elucidate the metabolic basis for the decreased LDL cholesterol and apo B levels in CETP deficiency. We conducted a series of in vivo apo B kinetic studies in tow unrelated homozygotes with CETP deficiency and in control subjects. A primed constant infusion of stable isotopically labeled phenylalanine was administered to the two CETP deficient subjects and control subjects and apo B kinetic parameters in VLDL, intermediate density lipoproteins, and LDL were obtained by using a multicompartmental model. The fractional catabolic rates (FCR) of LDL apo B were significantly increased in the CETP-deficient subjects (0.56 and 0.75/d) compared with the controls (mean FCR of 0.39/d). Furthermore, the production rates of apo B in VLDL and intermediate density lipoprotein were decreased by 55% and 81%, respectively, in CETP deficiency compared with the controls. In conclusion, CETP-deficient subjects were demonstrated to have substantially increased catabolic rates of LDL apo B as the primary metabolic basis for the low plasma levels of LDL apo B. This result indicates that the LDL receptor pathway may be up-regulated in CETP deficiency.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol

Related Publications

K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins.
August 1984, The Journal of biological chemistry,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin.
January 1991, Journal of lipid research,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
August 1994, Journal of biochemistry,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity.
March 1988, Atherosclerosis,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency.
November 2000, Clinica chimica acta; international journal of clinical chemistry,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
[Cholesteryl ester transfer protein deficiency].
March 2001, Nihon rinsho. Japanese journal of clinical medicine,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
May 1992, Biochimica et biophysica acta,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Human plasma cholesteryl ester transfer protein enhances the transfer of cholesteryl ester from high density lipoproteins into cultured HepG2 cells.
March 1987, The Journal of biological chemistry,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency.
January 1991, Arteriosclerosis and thrombosis : a journal of vascular biology,
K Ikewaki, and M Nishiwaki, and T Sakamoto, and T Ishikawa, and T Fairwell, and L A Zech, and M Nagano, and H Nakamura, and H B Brewer, and D J Rader
Direct isolation of labeled low density lipoproteins for the determination of cholesteryl ester transfer protein activity.
October 1997, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!